Delivery Order SPE2DB22D2005-SPE2DB24FJNH4

Award Date 6/4/24
Potential Completion Date 6/5/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluorometholone 0.1% eye drops. The order has a ceiling value of $15,811.15 and an ultimate completion date of August 29, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. As a significant supplier of pharmaceutical products and medical supplies to the federal government, Amerisourcebergen holds multiple...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,914.13 firm fixed-price contract is for the delivery of Fluorometholone 0.1% eye drops in 5ml bottles. The contract has an ultimate completion date of June 14, 2024. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,334.79 firm fixed-price contract is for the supply of Fluorometholone 0.1% eye drops (10 mL). The contract has an ultimate completion date of November 18, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.52 firm fixed-price contract is for the supply of Fluorometholone 0.1% eye drops, a pharmaceutical product, to support military healthcare programs. The contract has a performance period through May 31, 2024 and does not include any set-aside designation, indicating open...
This is a $5,033.30 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Fluorometholone 0.1% eye drops, a specialty pharmaceutical product. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluorometholone 0.1% eye drops, a prescription ophthalmic medication, with a ceiling value of $1,328.09. The contract is a firm fixed-price Delivery Order with a period of performance through March 7, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $7,092.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, for the delivery of Fluorometholone 0.1% eye drops in 5ml vials. The contract is a firm fixed price delivery order with an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
This federal contract award is for the delivery of Fluorometholone 0.1% eye drops, 5ml, to the Defense Logistics Agency (DLA). The $1,091.97 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 31, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,748.86, is for the delivery of Fluorometholone 0.1% Eye Drops in 10 mL sizes. The contract is a Firm Fixed Price Delivery Order, with a completion date of June 12, 2024. The contract was not designated under any set-aside program. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,376.83, is for the supply of Fluorometholone 0.1% Eye Drop 5ML, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2024 and is a firm fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJNH4
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Fluorometholone 0.1% eye drops. The contract, valued at $10,439.84, has a firm fixed price and a completion date of June 5, 2024. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 12:41 PM